Browse Articles
Discover research articles across all indexed journals
Deciphering Langerhans cell histiocytosis
Decoupling and peak prediction of industrial land carbon emissions in East China for developing countries’ prosperous regions
Optimization of ultrasound-assisted deep eutectic solvents extraction of rutin from Ilex asprella using response surface methodology
Application of deep learning for fruit defect recognition in Psidium guajava L
Beyond boundaries a hybrid cellular potts and particle swarm optimization model for energy and latency optimization in edge computing
Abstract The need to compute data in real-time and manage resources in environments with distributed computing has given edge computing significant importance. However, one of the most critical tasks regarding resources has been to schedule and optimize them in accordance with energy consumption and delay time. These challenges has been addressed in this paper with the introduction of a new integrated method that assumes the Cellular Potts Model and Particle Swarm Optimization. The Cellular Potts Model is used to capture local interaction and dependencies of resources, while PSO acts as a global optimizer for scheduling reducing latency and energy consumption. Based on these considerations, the primary research goal of this work is to mitigate the QoS requirements like energy consumption and end-to-end delay using CPM—spatial modeling complemented by PSO - the global optimization. Based on experimental analysis, the authors of the paper argue that the newly proposed Hybrid model consumes less energy and has less processing time than Round-Robin, Random Offloading, and Threshold-Based techniques. In addition, the approach achieves higher scalability and can perform a large of tasks and edge nodes with a high QoS while working in a resource-limited environment. This paper contributes to presenting the integration procedure of the CPM’s local optimization with the PSO’s global search, which offers high-performance and real-time solutions for resource scheduling in the edge computing environment. The results presented in the paper show that the proposed hybrid CPM-PSO model can offer greater potential as a tool for energy-constrained and time-sensitive applications within the future development of edge computing.
Multimorbidity, medications, and their association with falls, physical activity, and cognitive functions in older adults: multicenter study in Sri Lanka
External Li supply reshapes Li deficiency and lifetime limit of batteries
Remote sensing estimation of aboveground biomass of different forest types in Xinjiang based on machine learning
Aqueous-based recycling of perovskite photovoltaics
Abstract Cumulative silicon photovoltaic (PV) waste highlights the importance of considering waste recycling before the commercialization of emerging PV technologies1,2. Perovskite PVs are a promising next-generation technology3, in which recycling their end-of-life waste can reduce the toxic waste and retain resources4,5. Here we report a low-cost, green-solvent-based holistic recycling strategy to restore all valuable components from perovskite PV waste. We develop an efficient aqueous-based perovskite recycling approach that can also rejuvenate degraded perovskites. We further extend the scope of recycling to charge-transport layers, substrates, cover glasses and metal electrodes. After repeated degradation–recycling processes, the recycled devices show similar efficiency and stability compared with the fresh devices. Our holistic recycling strategy reduces by 96.6% resource depletion and by 68.8% human toxicity (cancer effects) impacts associated with perovskite PVs compared with the landfill treatment. With recycling, the levelized cost of electricity also decreases for both utility-scale and residential systems. This study highlights unique opportunities of perovskite PVs for holistic recycling and paves the way for a sustainable perovskite solar economy.
Design of a tunable multichannel terahertz absorber in one-dimensional photonic crystals incorporating a Dirac semimetal-dielectric defect layer
Understanding key population drivers of the spotted wing Drosophila in cultivated and natural areas in the Andes
The structure of bad cholesterol comes into focus
Design of parallel cascade controller for nonlinear continuous stirred tank reactor
Abstract This work presents an approach to control the temperature of a nonlinear continuous stirred tank reactor (NCSTR) through parallel cascade control structure (PCCS). For the first time, PCCS is used to control the temperature of NCSTR by (1) modelling the dynamic behavior of CSTR with a recirculating jacket heat transfer system into a third order unstable transfer function and (2) using the model matching technique to synthesize the controller parameters. The controller of the secondary loop of PCCS is designed to achieve enhanced regulatory performance whereas, the primary loop controller is designed for better setpoint tracking. The closed loop performance of the proposed method is evaluated by carrying out simulation on the differential equation of the NCSTR and comparing it with other structures such as series cascade control structure (CCS) and parallel control structure (PCS). The response shows that the proposed method provides satisfactory performance in nominal, perturbed and noisy conditions.
Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years
We present 10-year results of the phase Ⅲ FOWARC trial, which evaluated the efficacy of modified infusional fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) with or without radiation compared with fluorouracil with radiation in patients with locally advanced rectal cancer. A total of 495 patients age 18-75 years with stage Ⅱ-Ⅲ rectal cancer were randomly assigned to three treatment arms: fluorouracil plus radiotherapy, mFOLFOX6 plus radiotherapy, or mFOLFOX6 alone, followed by surgery and adjuvant chemotherapy. With a median follow-up of 10 years, the 10-year disease-free survival (DFS) rates were 52.5%, 62.6%, and 60.5%, respectively ( P = .56). The 10-year locoregional recurrence (LR) rates were 10.8%, 8.0%, and 9.6% ( P = .57), and the 10-year overall survival (OS) rates were 65.9%, 72.3%, and 73.4% ( P = .90). Subgroup analysis identified ypTNM stage as a significant prognostic factor for DFS, LR, and OS ( P < .0001, P < .006, P < .0001, respectively). Patients achieving pathologic complete response had 10-year DFS, LR, and OS rates of 84.3%, 3.0%, and 92.4%, respectively. No significant difference was observed in long-term survival outcome between mFOLFOX6 with and without radiation and fluorouracil plus radiation. These results demonstrate that neoadjuvant mFOLFOX6 chemotherapy can be considered as a therapeutic option in LARC.
A study of the purchase intention of alternative foods
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma
PURPOSE Pharmacologic therapies for neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PNs) are limited; currently, none are US Food and Drug Administration–approved for adults. METHODS ReNeu is an open-label, multicenter, pivotal, phase IIb trial of mirdametinib in 58 adults (≥18 years of age) and 56 children (2 to 17 years of age) with NF1-PN causing significant morbidities. Patients received mirdametinib capsules or tablets for oral suspension (2 mg/m 2 twice daily, maximum 4 mg twice daily), regardless of food intake, in 3 weeks on/1 week off 28-day cycles. The primary end point was confirmed objective response rate (ORR; proportion of patients with a ≥20% reduction of target PN volume from baseline on consecutive scans during the 24-cycle treatment phase) assessed by blinded independent central review (BICR) of volumetric magnetic resonance imaging. RESULTS Twenty-four of 58 adults (41%) and 29 of 56 children (52%) had a BICR-confirmed objective response during the 24-cycle treatment phase; in addition, two adults and one child had confirmed responses during long-term follow-up. Median (range) target PN volumetric best response was –41% (−90 to 13) in adults and –42% (−91 to 48) in children. Both cohorts reported significant and clinically meaningful improvement in patient- or parent proxy-reported outcome measures of worst tumor pain severity, pain interference, and health-related quality of life (HRQOL) that began early and were sustained during treatment. The most commonly reported treatment-related adverse events were dermatitis acneiform, diarrhea, and nausea in adults and dermatitis acneiform, diarrhea, and paronychia in children. CONCLUSION In ReNeu, the largest multicenter NF1-PN trial reported to date, mirdametinib treatment demonstrated significant confirmed ORRs by BICR, deep and durable PN volume reductions, and early, sustained, and clinically meaningful improvement in pain and HRQOL. Mirdametinib was well-tolerated in adults and children.
Mortality rates in physician staffed ground vs. air ambulance for severe trauma patients: retrospective analysis of the Japanese nationwide trauma registry
Redefining Available Therapy in Oncology Accelerated Approval Decisions
When weighing rapid approval for follow-on drugs, should @FDAOncology recognize the drugs that came before?